Management of primary immune thrombocytopenia. A comparison between two historical cohorts

Rodeghiero, 2009, Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group, Blood., 113, 2386, 10.1182/blood-2008-07-162503 Provan, 2010, International consensus report on the investigation and management of primary immune thrombocytopenia, Blood., 115, 168, 10.1182/blood-2009-06-225565 Monteagudo, 2011, Protocol for the study and treatment of immune thrombocytopenic purpura (ITP). ITP-2010, An Pediatr (Barc)., 74 Neunert, 2011, The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia, Blood., 117, 4190, 10.1182/blood-2010-08-302984 Revel-Vilk, 2013, Age and duration of bleeding symptoms at diagnosisbest predict resolution of childhood immune thrombocytopeniaat 3, 6, and 12 months, J Pediatr., 163, 10.1016/j.jpeds.2013.06.018 Treutiger, 2007, Does treatment of newly diagnosed idiopat-hic thrombocytopenic purpura reduce morbidity?, Arch Dis Child., 92, 704, 10.1136/adc.2006.098442 Imbach, 2003, New developments in idiopat-hic thrombocytopenic purpura (ITP): cooperative, prospectivestudies by the Intercontinental Childhood ITP Study Group, J Pediatr Hematol Oncol., 25, S74, 10.1097/00043426-200312001-00017 Zeller, 2005, Childhood idiopathic thrombocytopenicpurpura in the Nordic countries: epidemiology and predictorsof chronic disease, Acta Paediatr., 94, 178, 10.1080/08035250410025294 ElAlfy, 2010, Predictors of chronicidiopathic thrombocytopenic purpura, Pediatr Blood Cancer., 54, 959, 10.1002/pbc.22481 Monteagudo, 2019, Protocol for the study and treatment of pri-mary immune thrombocytopenia: PTI-2018, An Pediatr (Barc)., 91, 10.1016/j.anpedi.2019.04.014